718 results on '"Margolin, David"'
Search Results
2. Anastomotic Construction
3. Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058
4. Are the current colonoscopy recommendations for interval surveillance in patients with polyps enough? Machine learning-augmented propensity score cohort analysis of 1840 patients
5. Post-polypectomy Bleeding
6. Anastomotic Construction
7. Presacral Bleeding
8. Retrorectal (Presacral) Tumors
9. CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin
10. Perfusion assessment in laparoscopic left-sided/anterior resection (PILLAR II): a multi-institutional study.
11. Retrorectal (Presacral) Tumors
12. Advances in colonoscopy and screening for colon cancer
13. Sigmoid Colectomy and Left Hemicolectomy: Hand-Assisted Laparoscopic Approach
14. Stimulation of HIV-1-Neutralizing Antibodies in Simian HIV-IIIB-Infected Macaques
15. Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies
16. Comparison of 30-Day Postoperative Outcomes after Laparoscopic vs Robotic Colectomy
17. sj-docx-1-mso-10.1177_20552173221142741 - Supplemental material for Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies
18. NATURAL GAS PRICES AND THE EXTREME WINTERS OF 2011/12 AND 2013/14 : Causes, Indicators, and Interactions
19. Health-Care Economics
20. The Role of Bowel Preparation in Colorectal Surgery: Results of the 2012–2015 ACS-NSQIP Data
21. Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial
22. SOLAR ENERGY PREDICTION : An International Contest to Initiate Interdisciplinary Research on Compelling Meteorological Problems
23. Emerging Trends in the Etiology, Prevention, and Treatment of Gastrointestinal Anastomotic Leakage
24. Health Care Economics
25. Morbidity Following Coloanal Anastomosis: A Comparison of Colonic J-Pouch vs Straight Anastomosis
26. 1127 Pregnancy outcomes in alemtuzumab trials and registry design
27. Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy
28. Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings
29. The Role of Transanal Surgery in the Management of T1 Rectal Cancers
30. A Phase I, First-in-Human, Healthy Volunteer Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN424, a Novel G Protein-Coupled Receptor 6 Inverse Agonist for Parkinson’s Disease
31. Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes
32. Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058
33. Current status: new technologies for the treatment of patients with fecal incontinence
34. Management of Colorectal Anastomotic Leak
35. Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial
36. Sigmoid Colectomy and Left Hemicolectomy: Hand-Assisted Laparoscopic Approach
37. sj-pdf-1-tan-10.1177_1756286420982134 – Supplemental material for Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial
38. Cancer Stem Cells and the Stromal Microenvironment
39. Identification of CVN058, a Novel Brain Penetrant, Selective 5-HT3 Receptor Antagonist That Shows Efficacy in Pre-Clinical Cognition Models
40. CVN058, a 5-HT3 Receptor Antagonist, Shows Acute, Dose Dependent Improvement of Mismatch Negativity in a Double-Blind, Placebo-Controlled, Single Dose Cross-Over Study in Schizophrenia and Schizoaffective Disorder
41. Outcomes in Alemtuzumab-Treated Patients With Thyroid Adverse Events: 6-Year Pooled CARE-MS Data (1509)
42. Caveolin‐1‐driven membrane remodelling regulates hnRNPK‐mediated exosomal microRNA sorting in cancer
43. Health-Care Economics
44. The Ring of Dancers : Images of Faroese Culture
45. Infection Rates in a Large Investigational Trial of Sacral Nerve Stimulation for Fecal Incontinence
46. Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients With Relapsing-Remitting Multiple Sclerosis
47. Are the current colonoscopy recommendations for interval surveillance in patients with polyps enough? Machine learning-augmented propensity score cohort analysis of 1840 patients
48. Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial
49. sj-pdf-1-mso-10.1177_2055217320972137 - Supplemental material for Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years
50. The Importance of Colonoscopy in Colorectal Surgeons’ Practices: Results of a Survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.